These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 34351424)
1. Erratum to: Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". J Clin Endocrinol Metab; 2021 Nov; 106(12):e5284. PubMed ID: 34351424 [No Abstract] [Full Text] [Related]
2. Response to Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". Marino R; Perez Garrido N; Ramirez P; Belgorosky A J Clin Endocrinol Metab; 2021 Jun; 106(7):e2837-e2838. PubMed ID: 33901286 [No Abstract] [Full Text] [Related]
3. Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clirnical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". Lao Q; Merke DP J Clin Endocrinol Metab; 2021 Jun; 106(7):e2835-e2836. PubMed ID: 33901292 [No Abstract] [Full Text] [Related]
6. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency. Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442 [TBL] [Abstract][Full Text] [Related]
7. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module. Lee HH Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189 [TBL] [Abstract][Full Text] [Related]
8. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X. Kolli V; Kim H; Rao H; Lao Q; Gaynor A; Milner JD; Merke DP BMC Res Notes; 2019 Oct; 12(1):711. PubMed ID: 31666125 [TBL] [Abstract][Full Text] [Related]
9. High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. Lao Q; Brookner B; Merke DP J Mol Diagn; 2019 Sep; 21(5):924-931. PubMed ID: 31229653 [TBL] [Abstract][Full Text] [Related]
14. Unusual Combination of MEN-1 and the Contiguous Gene Deletion Syndrome of CAH and Ehlers-Danlos Syndrome (CAH-X). Chen Cardenas SM; El-Kaissi S; Jarad O; Liaqat M; Korbonits M; Hamrahian AH J Endocr Soc; 2020 Aug; 4(8):bvaa077. PubMed ID: 32715272 [TBL] [Abstract][Full Text] [Related]
15. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569 [TBL] [Abstract][Full Text] [Related]
16. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module. Lee HH; Lee YJ; Lin CY Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125 [TBL] [Abstract][Full Text] [Related]
17. Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome. Miller WL; Merke DP Horm Res Paediatr; 2018; 89(5):352-361. PubMed ID: 29734195 [TBL] [Abstract][Full Text] [Related]
18. Congenital adrenal hyperplasia, ovarian failure and Ehlers-Danlos syndrome due to a 6p deletion. Moysés-Oliveira M; Mancini TI; Takeno SS; Rodrigues AD; Bachega TA; Bertola D; Melaragno MI Sex Dev; 2014; 8(4):139-45. PubMed ID: 24970489 [TBL] [Abstract][Full Text] [Related]
19. Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel Rymen D; Ritelli M; Zoppi N; Cinquina V; Giunta C; Rohrbach M; Colombi M Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31731524 [TBL] [Abstract][Full Text] [Related]